Nkarta: Pushing Deeper Into A Discount Vs. Their Holdings, For No Real Reason (NKTX)

Nkarta Inc. ( NKTX ) is a company I've covered a few times in 2025, coming away each time with an optimistic outlook for their pivot into autoimmune disease with theirI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in this space.Analyst’s Disclosure:I ...